Home  >  Products  >  CREBBP (CREB binding protein (Rubinstein-Taybi syndrome)) Blocking Peptide (the N terminal of protein) (100ug)
CREBBP (CREB binding protein (Rubinstein-Taybi syndrome)) Blocking Peptide (the N terminal of protein) (100ug)

CREBBP (CREB binding protein (Rubinstein-Taybi syndrome)) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-CREBBP antibody (Catalogue #: ARP43609_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP43609
Size: 100 ug
Weight: 261kDa
Gene: 1387
Format: Lyophilized powder
Target: CREBBP is involved in the transcriptional coactivation of many different transcription factors. First isolated as a nuclear protein that binds to cAMP-response element binding protein (CREB), this gene is now known to play critical roles in embryonic development, growth control, and homeostasis by coupling chromatin remodeling to transcription factor recognition. CREBBP has intrinsic histone acetyltransferase activity and also acts as a scaffold to stabilize additional protein interactions with the transcription complex. This protein acetylates both histone and non-histone proteins. This protein shares regions of very high sequence similarity with protein p300 in its bromodomain, cysteine-histidine-rich regions, and histone acetyltransferase domain.
Alternative names: CBP; KAT3A; RSTS; RTS
See Full Product Listings >